GlassScriptPrepare for your visit
Jae Yoon Park
Interventional Cardiology · Tucson, AZ · NPI 1962798397
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$7,452.38
in general payments reported to CMS, 2019-2025 · $272 in 2025
The $272 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Who reported paying
General payments only, top 6 by amount.
- Medtronic, INC. $1,783.07
- Edwards Lifesciences Corporation $1,047.29
- Boston Scientific Corporation $878.22
- Abbott Laboratories $860.95
- Philips North America LLC $792.41
- Actelion Pharmaceuticals US, INC. $477.04
Drugs and devices associated with these payments
Edwards Sapien 3 Transcatheter Heart Valve (Thv) Corevalve Evolut R Opsumit Uptravi Lifevest Enroute Transcarotid Neuroprotection System Enroute Transcarotid Stent Assure Wcd Pascal Barostim Neo System Jardiance Leqvio
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Jae Yoon Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/903087/jae-yoon-park